EuroEspes, S.A. acquired an additional 50.05% stake in Ebiotec S.A from Inversora Portichol S.L.
September 24, 2014 at 09:30 am IST
Share
EuroEspes, S.A. (CATS:EEP) acquired an additional 50.05% stake in Ebiotec S.A from Inversora Portichol S.L. on September 23, 2014. Following the transaction, EuroEspes owns 90% stake in Ebiotec S.A. The transaction was approved by the shareholders of EuroEspes, S.A.
EuroEspes, S.A. (CATS:EEP) completed the acquisition of an additional 50.05% stake in Ebiotec S.A from Inversora Portichol S.L. on September 23, 2014.
Euroespes SA is a Spain-based company engaged in the healthcare sector. The Company operates a medical center, which focuses on the prevention, diagnosis and treatment of central nervous system disorders, such as Alzheimer and Parkinson, and other common diseases. The Companyâs medical offer includes personalized treatment plans, genomic medicine, epigenetics, neuropsychology, neuro-ophthalmology, digital diagnosis, diagnostic imaging, clinical analysis and nursing services, among others. In addition, it provides pharmacogenetics services and Human Identification Genetics card, which identifies user's deoxyribonucleic acid (DNA) profile. The Company operates through a number of subsidiaries, such as in Euroespes Biotecnologia SA, Distribuidora de Productos SL and Ebiotec Pharma SL.